Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
TELO
TELO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest TELO ETF News Today | Earnings, Events & Price Alerts
TELO News
Coinbase CEO Armstrong Invests in NewLimit, Secures $45 Million Funding
Jan 06 2026
Benzinga
Friday's Underperformers: Pharmaceutical, Oil, and Gas Exploration & Production Shares
Oct 10 2025
NASDAQ.COM
Stock Market Update: Dow Jones and Nasdaq Futures Decline as Trade Deficit Data Release is Postponed Due to Shutdown—Trilogy Metals, AMD, and Applovin Under Scrutiny
Oct 07 2025
Benzinga
TELO, PCSA, RVPH, NMTC, BRTX Experience After-Hours Trading Surge Amid Limited News and Specific Updates
Oct 07 2025
NASDAQ.COM
Stock Market Update: Nvidia Weighs on Nasdaq Futures—Attention on Dollar General, Dell, and Best Buy
Aug 28 2025
Benzinga
Snowflake Shares Surge 14%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 28 2025
Benzinga
Reasons Behind the 35% Surge in Telomir Pharmaceuticals Stock on Wednesday Night
Aug 28 2025
Benzinga
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Jul 21 2025
Benzinga
Dow Falls Over 200 Points; 3M Earnings Top Views
Jul 18 2025
Benzinga
US Stocks Mixed; American Express Posts Upbeat Q2 Results
Jul 18 2025
Benzinga
Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today?
Jul 18 2025
TipRanks
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Jul 18 2025
Benzinga
US Stocks Likely To Open Higher After Scaling Record Close: American Express, 3M, Charles Schwab Earnings In Focus
Jul 18 2025
Benzinga
Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests
Jul 18 2025
Benzinga
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
Jun 18 2025
Benzinga
EXCLUSIVE: Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder
Jun 05 2025
Benzinga
Show More News
